Kevin Tracey serves as Executive at UNITED THERAPEUTICS Corp, where they oversee executive responsibilities. Since joining the company, Kevin Tracey has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 21, 2026 involved receiving (via award) 1,220 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | UTHR | $0 | Award | 1,220 | $N/A | Discretionary |
Kevin Tracey currently holds 1,220 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Tracey has been a net neutral trader of UTHR stock. They have purchased $0 and sold $0 worth of shares.
Kevin Tracey's most recent insider trade was on Jan 21, 2026, when they sold 1,220 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted